US$ 29.70
common side effects of glp-1 drugs GI Adverse Glucagon-Like Peptide-1 Receptor Agonists Glucagon-like Receptor-1 agonists for obesity:
Description
Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels

This improved tolerability often leads to better treatment compliance, allowing for sustained therapeutic benefits

GLP-1 receptor agonists in obese patients with inflammatory bowel disease: from molecular mechanisms to clinical considerations and practical recommendations for safe and effective use

doi: 10.3389/fnagi.2019.00204 [DOI] [PMC free article] [PubMed] [Google Scholar] 35
Thus, it is not clear whether stimulation of GIP secretion by bile is mediated by GPBAR-1

Diabetes Care 26 , 23702377 (2003)
